The U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Aids Alabama Inc. (AAI). This 5-year grant will fund the "Living in Balance" project, which aims to implement an integrated care model to serve individuals with HIV/AIDS and substance use disorders in the greater...
The U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA) 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance program, awarded a $800,000 project grant to the Denver Health and Hospital Authority (Denver Health). The 5-year grant will establish the "JUST RECOVERY" program, which aims to provide integrated substance use disorder (SUD) treatment, medications for...
The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA) Community Health Centers program (CFDA 93.224), awarded APLA Health & Wellness a $600,000 Project Grant in Year 1 and $500,000 in Year 2 to expand access to behavioral health services for low-income communities, the LGBTQ+ population, individuals living with or at risk for HIV, and the general low-income residents near APLA Health's service delivery sites in Los Angeles,...
This Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA), under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, provides $280,000 to Westcare Georgia, Inc. to deliver a comprehensive set of substance use disorder prevention, treatment, and HIV/viral hepatitis prevention services in the Atlanta metropolitan area. The key products and services include: providing substance use prevention...
The U.S. Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Center for Health Justice, Inc., a Los Angeles-based non-profit organization. The grant, titled "Project HOPE," aims to implement substance use disorder (SUD) and co-occurring mental health treatment and...
The Alabama Department of Mental Health (ADMH) was awarded a $64,726,872 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant will provide $16,176,149 per year for 3 years, from September 2024 to September 2027, to serve 36,000 individuals in Alabama with treatment, prevention, and recovery support services for opioid use...
The federal Project Grant award H79TI086840 of $999,998 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. This funding supports the Integrated Outreach and Care (IOC) program, a partnership between several clinics within the Meharry Medical College academic medical center. The IOC program aims to (1) identify, engage, and support racial...
The U.S. Department of Health and Human Services (DHHS), Health Resources and Services Administration (HRSA) awarded a $300,000 Project Grant to West Alabama Aids Outreach Inc., doing business as Five Horizons Health Services, under the AIDS Education and Training Centers (AETC) Program (CFDA 93.145). The award, with a project period from September 1, 2024 to August 31, 2025, will support comprehensive HIV prevention, care, and treatment services targeting rural, medically underserved areas...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Erise Williams and Associates, Inc. to implement the "STL MADE: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at Risk for HIV/AIDS" project. The project aims to increase engagement in care for Black/African American individuals 18...
The U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) awarded a $600,000 Community Health Centers (CFDA 93.224) Project Grant to Alabama Regional Medical Services, doing business as Birmingham Health Care, to expand behavioral health and substance use disorder (SUD) services. The funding will be used to integrate a multi-disciplinary behavioral health team into the organization's primary care services, enabling comprehensive treatment of...
THE DEN - THRIVE ALABAMA'S BEHAVIORAL HEALTHCARE PROGRAM FOR HIGH RISK POPULATIONS - ALABAMA IS AMONG THE STATES HARDEST HIT BY THE HIV EPIDEMIC AND HAS SEEN AN INCREASE IN SUBSTANCE USE AND CO-OCCURRING DISORDERS (SUDS/CODS) SINCE THE ONSET OF THE COVID-19 PANDEMIC. ALABAMA IS ALREADY AMONG THE STATES WITH HIGH RATES OF SUDS/CODS AMONG ITS POPULATION. THE AIDS ACTION COALITION OF HUNTSVILLE D/B/A THRIVE ALABAMA (TA), A 501(C)(3) NON-PROFIT ORGANIZATION, FQHC, AND RYAN WHITE PROVIDER LOCATED IN HUNTSVILLE, ALABAMA, REQUESTS FUNDING FOR TA'S DEN INTENSIVE OUTPATIENT PROGRAM (IOP) TO MEET THE SUD/COD TREATMENT NEEDS OF MINORITY ADULTS AT-RISK OR POSITIVE FOR HIV IN TA'S NORTH ALABAMA SERVICE AREA. THE DEN IOP'S OVERALL GOAL IS TO PROVIDE ACCESSIBLE, EFFECTIVE, EVIDENCE-BASED INTENSIVE OUTPATIENT SUD/COD TREATMENT FOR AT-RISK MINORITY ADULTS THAT ADDRESSES THEIR NEEDS, INCLUDING HIV/HCV/HBV TESTING AND TREATMENT SERVICES, IN A CARING, TRAUMA-INFORMED, AND CULTURALLY COMPETENT ENVIRONMENT. THE DEN IOP WILL PROVIDE ASSERT, A CLINIC-BASED SCREENING AND BRIEF TREATMENT INTERVENTION, TO AT LEAST 120 PARTICIPANTS PER YEAR (600 OVER FIVE YEARS) TO IDENTIFY AND REFER CLIENTS IN NEED OF SUD OR COD TREATMENT TO THE DEN'S IOP OR OTHER PARTNERING RESOURCES. ALL PARTICIPANTS ARE OFFERED TESTS TO SCREEN FOR HIV AND VIRAL HEPATITIS B AND C TESTING AT MULTIPLE POINTS IN THE PROGRAM. THE DEN IOP EXPECTS SIXTY-FIVE OF THOSE SCREENED TO ENTER THE IOP PROGRAM EACH YEAR FOR A TOTAL OF 325 OVER FIVE YEARS. THE DEN IOP USES THE MATRIX MODEL, AN EVIDENCE-BASED PROGRAM ORIGINALLY DESIGNED FOR STIMULANT ABUSE AND DEPENDENCE. DEVELOPED THROUGH 20 YEARS OF EXPERIENCE IN REAL-WORLD TREATMENT SETTINGS, THE MATRIX MODEL IS ALSO USED FOR TREATMENT OF OTHER SUBSTANCE USE DISORDERS INCLUDING OPIOIDS. THE INTERVENTION CONSISTS OF A COGNITIVE BEHAVIORAL APPROACH USING MOTIVATIONAL INTERVIEWING, RELAPSE-PREVENTION GROUPS, EDUCATION GROUPS, SOCIAL-SUPPORT GROUPS, INDIVIDUAL COUNSELING, AND REFERRALS TO NEEDED COMMUNITY RESOURCES (E.G., PRIMARY MEDICAL CARE, HOUSING ASSISTANCE, VOCATIONAL REHABILITATION SERVICES). PATIENTS LEARN ABOUT ISSUES CRITICAL TO ADDICTION AND RELAPSE, RECEIVE DIRECTION AND SUPPORT FROM TRAINED THERAPISTS AND SUBSTANCE USE COUNSELORS, BECOME FAMILIAR WITH SELF-HELP PROGRAMS, AND ARE MONITORED FOR DRUG USE BY URINE AND BREATHALYZER TESTING THE DEN WHICH IS CERTIFIED BY THE ALABAMA DEPARTMENT OF MENTAL HEALTH, HAS OPERATED THROUGH SAMHSA FUNDING FOR THE PAST TEN YEARS. THE DEN PROVIDES EVIDENCE-BASED, TRAUMA-INFORMED, AND CULTURALLY COMPETENT CARE WITH SCREENING, TESTING, AND TREATMENT FOR AT-RISK MINORITY MEN AND WOMEN AND INDIVIDUALS WHO IDENTIFY AS LBGTQIA+ AND MEN WHO HAVE SEX WITH MEN (MSM). THE POPULATIONS OF FOCUS ARE AT HIGH RISK OF HIV AND VIRAL HEPATIS, AND OFTEN LACK ACCESS TO MEDICAL AND BEHAVIORAL HEALTHCARE. IN ADDITION TO SUD/COD TREATMENT THROUGH THE DEN PROJECT, THRIVE ALABAMA HAS THE EXPERIENCE AND RESOURCES TO PROVIDE TREATMENT, CASE MANAGEMENT AND SUPPORT SERVICES FOR CLIENT WHO NEED HIV OR VIRAL HEPATITIS B OR C TREATMENT.